LPHYSIO Funding Boosts Wellness Platform Expansion

South Korean firm LPHYSIO has successfully closed a follow-on funding round, securing approximately $200,000 (KRW 300 million). This capital infusion, provided by Star Asset Partners, is earmarked for expanding the company's comprehensive wellness platform beyond its established body care device sales.

The investment from Star Asset Partners was channeled through its specialized fund, the “K-Beauty Star SAP Individual Investment Association No. 1-P.” This latest injection follows an initial seed investment of roughly $66,700 (KRW 100 million) made in 2025 via a different Star Asset Partners vehicle. Combined, these two transactions represent a total club deal value of approximately $266,700 (KRW 400 million), underscoring a growing confidence in LPHYSIO's strategic direction.

LPHYSIO has built its reputation on premium aesthetic medical devices, including prominent models like the LPG CELLU M6 ALLIANCE and Thermawave series, which target body contouring and skin rejuvenation. The company's operational model integrates company-owned centers, serving as crucial testing grounds for equipment efficacy and service refinement, with a network of franchise locations. This dual approach allows LPHYSIO to gather valuable operational data and standardize treatment protocols and operational manuals, which are then disseminated to medical institutions and aesthetic clinics.

Significantly, LPHYSIO is strategically evolving from a device vendor into a holistic wellness solutions provider. Its expansion into health functional foods and inner beauty products signals a commitment to a more integrated approach to well-being, addressing consumer needs from both external and internal perspectives. This diversification aligns with the global wellness market, projected to reach trillions of dollars, with increasing consumer demand for comprehensive health and beauty solutions.

The decision by Star Asset Partners to increase its stake was heavily influenced by the robust leadership team at LPHYSIO. The company is co-led by executives possessing a potent blend of expertise: one CEO brings over 15 years of experience in hospital administration, while the other offers 16 years of dedicated experience in the medical device sales and distribution sector. This complementary skill set is seen as a critical asset for navigating the complexities of the healthcare and wellness industries.

Heesung Lee, CEO of Star Asset Partners, commented on the investment, highlighting LPHYSIO's unique position. He stated, “LPHYSIO transcends being merely an equipment supplier; it is a team equipped with an unparalleled fusion of medical management acumen and distribution proficiency. We were particularly impressed by their capacity to derive validated data from their owned centers and translate it into scalable treatment frameworks. We are confident in their potential to establish new benchmarks within the expansive total wellness market.” This strategic expansion and strong leadership position LPHYSIO for significant growth in the competitive beauty-tech and wellness sectors.